CRBU

Caribou Biosciences, Inc.

Biotechnology · Biotechnology

$88.95 sample

+1.24 (+1.41%) 1D

Market cap

$414.9B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-06

Alerts

8

Price$88.95 +13.10% 3M daily closessample

88.9578.65

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider buy: EVP, Operations
Oct 06SECDEF 14A filed
Sep 25INSInsider buy: Director
Sep 21SECDEF 14A filed
Sep 15INSInsider buy: Chief Executive Officer
Sep 04SEC8-K filed: material event
Aug 27INSInsider sell: General Counsel
Aug 18INSInsider buy: EVP, Operations

Sign up to see the real CRBU record →

Company facts

SEC EDGAR registration

Name: Caribou Biosciences, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -46sample, -100 to +100
Reporting currency: USD

Who is positioning in CRBU

sample

Insiders: 13 insider transactions over 90 days, net selling, $101.6M
Congress: 5 members traded over 90 days
Institutions · 13F: 43 funds hold $6.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$24.1B +20.7% y/y

Q4 2024Q3 2026

Inventory$13.9B +15.2% y/y

Q4 2024Q3 2026

Accounts receivable$10.2B +11.8% y/y

Q4 2024Q3 2026

Total debt$27.2B +6.5% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $161.0B +2.4% 3M
Sample peer B: $174.7B -12.8% 3M
Sample peer C: $299.7B -8.8% 3M
Sample peer D: $163.7B -5.2% 3M
Sample peer E: $375.2B +9.9% 3M